← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Owner-earnings 10-yr IRR 10–30 points over Treasuries, yield ≤ 25% · bought the day of the annual report, held 12 months
Could be luck Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +2.9 pts (823 entries, 255 companies, could be luck). 47% of entries beat the S&P; 18% beat it by 30 points or more; 27% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +1.2 pts.
+2.9 ptsvs S&P, average
47%beat the S&P
18%up 30+ pts vs S&P
27%down 20+ pts vs S&P
+6.0 ptsvs small caps, 12 mo
−14.6 pts 2024worst year to buy ?
1.8luck check ?
Does the holding period matter?3 mo: −0.5 pts 47% beat6 mo: +0.1 pts 45% beat12 mo: +2.9 pts 47% beat24 mo: +3.3 pts 42% beat3 yr, per yr: −0.9 pts 39% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today686+1.9 pts t 1.2+5.3 pts
Sell-off (S&P ≥10% off high)137+7.9 pts t 1.4+9.6 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing255+0.9 pts t 0.4−5.1 pts
Retail & consumer106+10.5 pts t 1.9+1.9 pts
Services79−3.2 pts t -0.5−1.9 pts
Energy69+3.1 pts t 0.5−4.9 pts
Other61−4.4 pts t -0.8−3.3 pts
Tech hardware & semis58−2.8 pts t -0.6−1.4 pts
Finance & real estate46+5.9 pts t 1.5+6.8 pts
Biotech & pharma28−5.0 pts t -0.7−4.3 pts

Holds up out of sample? Before 2018: +5.1 pts (n 291, t 2.3). From 2018: +1.7 pts (n 532, t 0.8). Same sign in both halves.

Year201120122013201420152016201720182019202020212022202320242025
vs S&P−11 pts+5 pts+6 pts−5 pts−4 pts+17 pts+8 pts−10 pts−14 pts+46 pts+8 pts+8 pts−14 pts−15 pts+3 pts
n12943515669425362725676876957

Read the research behind this screen: Ranking companies as equity bonds: the top fifth beats the bottom fifth by a wide margin → · Test your own combination in the Screen Lab →

Same definitions as the table: coupon = 3-yr average owner earnings, growth capped, 15× exit. Historical IRR uses a 5-yr revenue CAGR as the growth proxy where the DCF rate is not available point-in-time. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

PLTM
GraniteShares Platinum Trust
Below Treasuries
Financial Services Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PLTR
Palantir Technologies Inc.
Below Treasuries
Technology Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +45.8%/yr vs model +30.5% · above model
PLTS
Platinum Analytics Cayman Ltd
Below Treasuries
Technology Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +22.9%/yr vs model +50.0% · below model
PLUG
PLUG POWER INC
Below Treasuries
Technology Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +34.4%/yr vs model +9.0% · above model
PLUR
Pluri Inc.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +15.2%/yr vs model +15.0% · in line
PLUT
Plutus Financial Group Ltd
Below Treasuries
Financial Services Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +34.6%/yr vs model +15.0% · above model
PLX
Protalix BioTherapeutics, Inc.
Below Treasuries
Healthcare Risk 29 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +28.7%/yr vs model +8.3% · above model
PLYX
Polaryx Therapeutics, Inc.
Below Treasuries
Healthcare Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMAX
Powell Max Ltd
Below Treasuries
Technology
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMCB
PharmaCyte Biotech, Inc.
Below Treasuries
Healthcare Risk 28 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PML
PIMCO MUNICIPAL INCOME FUND II
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMM
PUTNAM MANAGED MUNICIPAL INCOME TRUST
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMN
ProMIS Neurosciences Inc.
Below Treasuries
Healthcare Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMO
PUTNAM MUNICIPAL OPPORTUNITIES TRUST
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMTR
Perimeter Acquisition Corp. I
Below Treasuries
Financial Services Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMTRU
Perimeter Acquisition Corp. I
Below Treasuries
Financial Services Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMTRW
Perimeter Acquisition Corp. I
Below Treasuries
Financial Services Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PMVP
PMV Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PNI
PIMCO NEW YORK MUNICIPAL INCOME FUND II
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
POAS
PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd
Below Treasuries
Healthcare Risk 30 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +17.2%/yr vs model +15.0% · in line
POET
POET TECHNOLOGIES INC.
Below Treasuries
Technology Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
POLE
Andretti Acquisition Corp. II
Below Treasuries
Financial Services Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
POLEU
Andretti Acquisition Corp. II
Below Treasuries
Financial Services Risk 50 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
POLEW
Andretti Acquisition Corp. II
Below Treasuries
Financial Services Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
POM
POMDOCTOR Ltd
Below Treasuries
Consumer Cyclical Risk 64 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -30.5%/yr vs model +15.0% · below model
PONO
Pono Capital Four, Inc.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PONOR
Pono Capital Four, Inc.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PONOU
Pono Capital Four, Inc.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PONY
Pony AI Inc.
Below Treasuries
Technology Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +68.7%/yr vs model +9.6% · above model
POWI
POWER INTEGRATIONS INC
Below Treasuries
Technology Risk 43 · Elevated
Yield2.2%
Growth used-1.9%
10-yr IRR-7.4%
Steady compounder · 5 yrs positive P/IV —
Market implies +33.0%/yr vs model -1.9% · above model
POWW
Outdoor Holding Co
Below Treasuries
Technology Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +77.9%/yr vs model +15.0% · above model
POWWP
Outdoor Holding Co
Below Treasuries
Technology Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +40.9%/yr vs model +2.0% · above model
PPBT
PURPLE BIOTECH LTD.
Below Treasuries
Healthcare Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PPCB
Propanc Biopharma, Inc.
Below Treasuries
Healthcare Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PPT
PUTNAM PREMIER INCOME TRUST
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PPTA
PERPETUA RESOURCES CORP.
Below Treasuries
Basic Materials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +92.7%/yr vs model +5.0% · above model
PRAX
Praxis Precision Medicines, Inc.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +87.0%/yr vs model +15.0% · above model
PRE
Prenetics Global Ltd
Below Treasuries
Healthcare Risk 29 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PRENW
Prenetics Global Ltd
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PRFX
PRF Technologies Ltd.
Below Treasuries
Healthcare Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +59.8%/yr vs model +15.0% · above model
PRHIZ
Presurance Holdings, Inc.
Below Treasuries
Financial Services Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PRLD
Prelude Therapeutics Inc
Below Treasuries
Healthcare Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +64.0%/yr vs model +15.0% · above model
PRM
Perimeter Solutions, Inc.
Below Treasuries
Basic Materials Risk 49 · Elevated
Yield2.6%
Growth used8.0%
10-yr IRR1.3%
Moderate grower · 3 yrs positive P/IV —
Market implies +29.6%/yr vs model +8.0% · above model
PRME
Prime Medicine, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +88.0%/yr vs model +15.0% · above model
PROF
Profound Medical Corp.
Below Treasuries
Healthcare Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +37.5%/yr vs model +15.0% · above model
PROK
PROKIDNEY CORP.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PROP
Prairie Operating Co.
Below Treasuries
Energy Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +11.3%/yr vs model +4.0% · above model
PRQR
ProQR Therapeutics N.V.
Below Treasuries
Healthcare Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PRT
PermRock Royalty Trust
Below Treasuries
Energy
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PRTA
PROTHENA CORP PUBLIC LTD CO
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +72.8%/yr vs model +2.0% · above model
PRZO
ParaZero Technologies Ltd.
Below Treasuries
Industrials Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +43.5%/yr vs model +9.6% · above model
PS
PERSHING SQUARE INC.
Below Treasuries
Financial Services Risk 58 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PSF
Cohen & Steers Select Preferred & Income Fund, Inc.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PSFE
Paysafe Ltd
Below Treasuries
Technology Risk 62 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -29.1%/yr vs model +3.4% · below model
PSLV
Sprott Physical Silver Trust
Below Treasuries
Financial Services Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PSNL
Personalis, Inc.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +95.8%/yr vs model +2.0% · above model
PSNY
Polestar Automotive Holding UK PLC
Below Treasuries
Consumer Cyclical
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PSNYW
Polestar Automotive Holding UK PLC
Below Treasuries
Consumer Cyclical
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PSO
PEARSON PLC
Below Treasuries
Communication Services Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
PSTV
PLUS THERAPEUTICS, INC.
Below Treasuries
Healthcare Risk 29 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +70.9%/yr vs model +15.0% · above model